Senior insider sale
Chief Medical Officer at BIONTECH SE — senior position signals high conviction
$20.85M
185K shares
What this filing means
TURECI OZLEM plans to sell 185K shares of BIONTECH SE valued at approximately $20.85M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/15/2025ACC: 0002044235-25-000001
Officer· Chief Medical Officer
Since Mar 2026
185K
Shares to sell
$20.85M
Approx. market value
185K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Stock Option Exercise
Stock Option Exercise
11/21/2022
185KTotal acquired185K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
11/21/2022 | Stock Option Exercise Stock Option Exercise | 185K | — |
| Total | 185K | ||
Planned & Completed Dispositions1
Nasdaq Global SelectPlanned
Units to sell
185K
Market value
$20.85M
8/15/2025
Total
Units
185K
Value
$20.85M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/15/2025 | 185K | $20.85M | Nasdaq Global Select | Planned |
| Total | 185K | $20.85M | ||